Hoffmann-La Roche, Inc. - Hoffmann-La Roche is the US prescription pharmaceuticals unit of Roche Group, which operates businesses ranging from pharmaceuticals to vitamins and diagnostic products. The company develops and makes drugs to treat such life-threatening conditions as AIDS, cancer, and heart disease. The company also provides treatments for central nervous system and mental disorders (Valium), influenza (Tamiflu), and obesity (Xenical). Hoffmann-La Roche has collaborative agreements with deCODE genetics, Affymetrix, and Incyte Genomics to develop new drugs.
340 Kingsland Street
Nutley, NJ 07110-1199 Phone:
(973) 235-5000 Fax:
(973) 235-7605 Website: http://www.rocheusa.com
Management InformationPresident & CEO
Mr. George Abercrombie
Company InformationEst. Revenue: $1000 Million
The contact, business and financial information provided above regarding Hoffmann-La Roche, Inc. is believed to be factual and up-to-date, but BB101 does not guarantee its accuracy. In some cases, estimated revenue has been calculated based on employee count and industry statistics. The information on these manufacturers and service companies may have changed recently so please contact the business itself for further information and data.
More Companies to Explore